Skip to menu Skip to content Skip to footer

2018

Conference Publication

The clinical significance of Mycobacterium triplex isolates in Queensland, Australia

Gibson, Justine, Baird, Tim, Pandy, Sushil, Tolson, Carla, Coulter, Chris, Eather, Geoffrey and Thomson, Rachel (2018). The clinical significance of Mycobacterium triplex isolates in Queensland, Australia. 28th International Congress of the European-Respiratory-Society (ERS), Paris France, Sep 15-19, 2018. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2018.PA344

The clinical significance of Mycobacterium triplex isolates in Queensland, Australia

2018

Conference Publication

PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION

Stockwell, R. E., Leong, L., Wheeler, N., Bryant, J., Wood, M. E., Sherrard, L., Thomson, R., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2018). PREVALENCE OF SHARED MYCOBACTERIUM ABSCESSUS COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION. HOBOKEN: WILEY.

PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION

2018

Conference Publication

Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis

Stockwell, R. E., Leong, L., Wood, M. E., Sherrard, L., Carter, R., Tolson, C., Thomson, R., Rogers, G., Wainwright, C. and Bell, S. C. (2018). Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Denver, CO, United States, 18-20 October 2018. Hoboken, NJ, United States: John Wiley & Sons.

Potable water as a possible source of mycobacterium abscessus complex infection in people with cystic fibrosis

2018

Conference Publication

Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)

Winthrop, K. L., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Griffith, D. E. (2018). Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC). International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.

Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)

2018

Conference Publication

Prevalence of nontuberculous mycobacteria (NTM) in potable water

Stockwell, R., Leong, L., Wood, M., Sherrard, L., Thomson, R., Rogers, G. and Bell, S. (2018). Prevalence of nontuberculous mycobacteria (NTM) in potable water. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Prevalence of nontuberculous mycobacteria (NTM) in potable water

2018

Conference Publication

Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients

Griffith, D. E., Eagle, G., Thomson, R. M., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L. C., Castellotti, P. F., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Nezamis, J. and Winthrop, K. L. (2018). Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients. International Conference of the American-Thoracic-Society, San Diego Ca, May 18-23, 2018. NEW YORK: AMER THORACIC SOC.

Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients

2017

Conference Publication

The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand

Visser, Simone, Allan, Heather, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Hunter, Cameron, Jackson, Dan, King, Paul, Maguire, Graeme, Middleton, Peter, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and Morgan, Lucy (2017). The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, Australia, 24–28 March 2017. Richmond, VIC Australia: Wiley.

The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand

2017

Conference Publication

The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand

Visser, S., Allan, H., Burr, L., Chang, A., Holmes-Liew, C. -L., Hunter, C., Jackson, D., King, P., Maguire, G., Middleton, P., Smith, D., Thomson, R., Waterer, G. W., Wong, C. and Morgan, L. (2017). The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand. International Conference of the American-Thoracic-Society (ATS), Washington Dc, May 19-24, 2017. NEW YORK: AMER THORACIC SOC.

The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand

2016

Conference Publication

Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients

Lutzky, , Ratnatunga, C., Thomson, R., Smith, D., Reid, D., Bell, S. and Miles, J. (2016). Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL.

Immunopathogenesis of non-tuberculous mycobacterial infection in cystic fibrosis patients

2016

Conference Publication

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction

Ratnatunga, C. N., Lutzky, V. P., Halstrom, S., Price, P., Smith, D. J., Reid, D. W., Bell, S. C., Thomson, R. M. and Miles, J. J. (2016). Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21 - 26 August 2016. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA. doi: 10.1002/eji.201670200

Multivariate immunoprofiling of individuals prone to non-tuberculous mycobacterial infection reveals T cell exhaustion and dysfunction

2015

Conference Publication

Validation of a non-tuberculous mycobacterial elisa in an australian cystic fibrosis and non-cystic fibrosis population

Cunningham, J., Thomson, R., Smith, D. and Bell, S. (2015). Validation of a non-tuberculous mycobacterial elisa in an australian cystic fibrosis and non-cystic fibrosis population. Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, Queensland, Australia, 27 March-1 April 2015. Richmond, VIC, Australia: John Wiley & Sons.

Validation of a non-tuberculous mycobacterial elisa in an australian cystic fibrosis and non-cystic fibrosis population

2015

Conference Publication

Validation of a nontuberculous mycobacterial Elisa in an Australian cystic fibrosis and non-systic fibrosis population

Cunningham, J., Smith, D. J., Bell, S. and Thomson, R. (2015). Validation of a nontuberculous mycobacterial Elisa in an Australian cystic fibrosis and non-systic fibrosis population. International Conference of the American-Thoracic-Society (ATS), Denver, CO, United States, 15 - 20 May 2015. New York, NY, United States: American Thoracic Society.

Validation of a nontuberculous mycobacterial Elisa in an Australian cystic fibrosis and non-systic fibrosis population

2015

Conference Publication

Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage

Scoleri, G., Leong, L., Burr, L., Choo, J., Thomson, R., Serisier, D. and Rogers, G. (2015). Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12494_8

Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage

2011

Conference Publication

Pathogenic nontuberculous mycobacteria in the Brisbane potable water distribution system

Thomson, R., Tolson, C., Carter, R., Coulter. C., Huygens, F. and Hargreaves, M. (2011). Pathogenic nontuberculous mycobacteria in the Brisbane potable water distribution system. American Thoracic Society 2011 International Conference, Denver, CO, U.S.A., May 13-18 2011. New York, NY, U.S.A.: American Thoracic Society.

Pathogenic nontuberculous mycobacteria in the Brisbane potable water distribution system